| # | Drug | Count |
|---|---|---|
| 0 | ALTEPLASE | 10 |
| 1 | DABIGATRAN ETEXILATE | 7 |
| 2 | DABIGATRAN ETEXILATE MESYLATE | 7 |
| 3 | METFORMIN | 2 |
| 4 | METFORMIN ER 500 MG | 2 |
| 5 | METFORMIN ER 750 MG | 2 |
| 6 | METHOTREXATE | 2 |
| 7 | METHOTREXATE SODIUM | 2 |
| 8 | RIVAROXABAN | 2 |
| 9 | VINCRISTINE SULFATE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACEBUTOLOL HYDROCHLORIDE | 1 | 0.0008 |
| 1 | ALTEPLASE | 10 | 0.0007 |
| 2 | TENECTEPLASE | 1 | 0.0006 |
| 3 | DABIGATRAN ETEXILATE MESYLATE | 7 | 0.0001 |
| 4 | DABIGATRAN ETEXILATE | 7 | 0.0001 |
| 5 | PEGASPARGASE | 1 | 0.0001 |
| 6 | LABETALOL | 1 | 0.0001 |
| 7 | VINCRISTINE SULFATE | 2 | 0.0001 |
| 8 | MERCAPTOPURINE | 1 | 0.0001 |
| 9 | NIRMATRELVIR AND RITONAVIR | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 1 | Factor Xa Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 6 | beta-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 1 | 0.0000 |